Thrombosis of the pulmonary arteries branches as a complication of COVID-19 pneumonia (a case report)
https://doi.org/10.18093/0869-0189-2021-31-4-537-541
Abstract
The article presents a rare case of thrombosis of the pulmonary arteries branches, which developed in a patient two months after infection with the SARS-CoV-2 virus, that caused bilateral polysegmental pneumonia. The thrombosis was suspected because of a high plasma D-dimer level. Contrast-enhanced chest CT was performed to make a definitive diagnosis. The absence of blood clots in the veins of the lower extremities and pelvis allowed us to conclude that the patient did not have thromboembolism, but rather a pulmonary thrombosis in situ. Such possible causes of venousthromboembolic complications as tumors, systemic diseases of the connective tissue, and antiphospholipid syndrome were excluded based on negative tests for tumor and autoimmune diseases markers. The long-stay in the hospital was associated with the inability of the patient to maintain the normal level of blood oxygen saturation independently due to the large area of the lung damage associated with COVID-19 pneumonia and ischemia caused by thrombosis of the branches of the pulmonary arteries.
About the Authors
T. I. KalenchicBelarus
Tamara I. Kalenchic, Candidate of Medicine, Associate Professor, Department of Medical Rehabilitation and Physiotherapy
Dzerzhinsky prosp. 83, Minsk, 220116
Competing Interests:
no
S. L. Kabak
Belarus
Sergey L. Kabak, Doctor of Medicine, Professor, Head of Department of Human Morphology
Dzerzhinsky prosp. 83, Minsk, 220116
Competing Interests:
no
N. S. Didenko
Russian Federation
Natalia S. Didenko, Сardiologist
ul. Nametkina 16, Moscow, 117420
Competing Interests:
no
I. P. Dulub
Belarus
Ivan P. Dulub, Head of the Pulmonology Department
ul. Uralskaya 5, Minsk, 220371
Competing Interests:
no
A. Yu. Haustovich
Belarus
Aleksandr Y. Haustovich, Radiologist
ul. Uralskaya 5, Minsk, 220371
Competing Interests:
no
References
1. Bělohlávek J., Dytrych V., Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp. Clin. Cardiol. 2013; 18 (2): 129–138.
2. Torbicki A., Perrier A., Konstantinides S. et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur. Heart J. 2008; 29 (18): 2276–2315. DOI: 10.1093/eurheartj/ehn310.
3. Rosovsky R.P., Grodzin C., Channick R. et al. Diagnosis and treatment of pulmonary embolism during the coronavirus disease 2019 pandemic: A Position Paper from the National PERT Consortium. Chest. 2020; 158 (6): 2590–2601. DOI: 10.1016/j.chest.2020.08.2064.
4. Sakr Y., Giovini M., Leone M. et al. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A narrative review. Ann. Intensive Care. 2020; 10: 124. DOI: 10.1186/s13613-020-00741-0.
5. Malas M.B., Naazie I.N., Elsayed N. et al. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedicine. 2020; 29: 100639. DOI: 10.1016/j.eclinm.2020.100639.
6. Porfidia A., Valeriani E., Pola R. et al. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thromb. Res. 2020; 196: 67–74. DOI: 10.1016/j.thromres.2020.08.020.
7. Kanso M., Cardi T., Marzak H. et al. Delayed pulmonary embolism after COVID-19 pneumonia: a case report. Eur. Heart J. Case Rep. 2020; 4 (6):1–4. DOI: 10.1093/ehjcr/ytaa449.
8. Vechi H.T., Maia L.R., Alves M.D.M. Late acute pulmonary embolism after mild coronavirus disease 2019 (COVID-19): a case series. Rev. Inst. Med. Trop. Sao Paulo. 2020; 62: e63. DOI: 10.1590/S1678-9946202062063.
9. Fox S.E., Akmatbekov A., Harbert J.L. et al. Pulmonary and cardiac pathology in COVID-19: The first autopsy series from New Orleans. MedRxiv. [Preprint. Posted: April 10, 2020]. DOI: 10.1101/2020.04.06.20050575.
10. Lax S.F., Skok K., Zechner P. et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: Results from a prospective, single-center, clinicopathologic case series. Ann. Intern. Med. 2020; 173 (5): 350–361. DOI: 10.7326/M20-2566.
11. Ahmed S., Zimba O., Gasparyan A.Y. Thrombosis in coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad. Clin. Rheumatol. 2020; 39 (9): 2529–2543. DOI: 10.1007/s10067-020-05275-1.
12. Hunt B., Retter A., McClintock C. Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19. 25th March, 2020. Available at: https://b-s-h.org.uk/media/18171/thand-covid-25-march-2020-final.pdf [Accessed: December 25, 2020].
13. Galstyan G.M. Coagulopathy in COVID-19. Pul’monologiya. 2020; 30 (5): 645–657. DOI: 10.18093/0869-0189-2020-30-5-645-657 (in English, Russian).
14. Eljilany I., Elzouki A.N. D-dimer, fibrinogen, and IL-6 in COVID-19 patients with suspected venous thromboembolism: a narrative review. Vasc. Health Risk Manag. 2020; 16: 455–462. DOI: 10.2147/VHRM.S280962.
15. Di Tano G., Moschini L., Loffi M. et al. Late pulmonary embolism after COVID-19 pneumonia despite adequate rivaroxaban treatment. Eur. J. Case Rep. Intern. Med. 2020; 7 (7): 001790. DOI: 10.12890/2020_001790.
Review
For citations:
Kalenchic T.I., Kabak S.L., Didenko N.S., Dulub I.P., Haustovich A.Yu. Thrombosis of the pulmonary arteries branches as a complication of COVID-19 pneumonia (a case report). PULMONOLOGIYA. 2021;31(4):537-541. (In Russ.) https://doi.org/10.18093/0869-0189-2021-31-4-537-541